Clinical Trial Update: Study of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial update for a combination of polymeric micellar paclitaxel, platinum, and sindilizumab in advanced non-squamous non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Platinum (Platinum-based chemotherapy)
• Polymeric micellar paclitaxel (paclitaxel)
• sindilizumab (sindilizumab)

Snippet

Sponsor: Jiangsu Cancer Institute & Hospital | Conditions: Non-squamous NSCLC | Phase 2 | Status: UNKNOWN